Avonex Share of First-Line Therapy Among Multiple Sclerosis Patients has …MarketWatch (press release)Patient profiles for the eight DMAs in late clinical development (Aubagio, BG-12, alemtuzumab, PEG-Avonex, Copaxone 40mg 3x weekly, daclizumab, laqui…
Kamada Announces New Data on its Glassia Drug Supporting its Diabetes … – Business Wire (press release)
Kamada Announces New Data on its Glassia Drug Supporting its Diabetes …Business Wire (press release)Based on the results, Kamada reports that its AAT protein is modulating the activity of type B lymphocytes and by that enables the avoidance of organ …
KAMADA LTD. : Kamada Announces New Data on its Glassia Drug Supporting … – 4-traders
KAMADA LTD. : Kamada Announces New Data on its Glassia Drug Supporting …4-tradersBased on the results, Kamada reports that its AAT protein is modulating the activity of type B lymphocytes and by that enables the avoidance of organ transplant rejectio…
Astellas and Ambit Announce Data Presentations Highlighting Quizartinib at the American Society of Hematology 54th …
TOKYO and SAN DIEGO, Nov. 6, 2012 /PRNewswire/ — Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation (Ambit) today announced that five oral presentations and three poster presentations …
Kamada Announces New Data on its Glassia Drug Supporting its Diabetes Activities and Treatment of Additional …
Kamada Ltd. , an Israeli biopharmaceutical company, specializing in development, manufacturing and marketing of specialty plasma bio-therapeutics by intravenous or inhaled route for life saving uses is now reporting a new promise stemming from several …
Stem cell therapy no good post heart stroke – Times of India
Stem cell therapy no good post heart strokeTimes of IndiaBoth TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute. "This study was extre…
Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM … – MarketWatch (press release)
Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM …MarketWatch (press release)Cleveland BioLabs Announces Publication of Studies on Effect of Entolimod(TM) (CBLB502) on Graft-Versus-Tumor Activity in Models of Allogeneic Bo…
Villagers in Eastern Nepal sells kidney to meet basic needs – Global Times
Villagers in Eastern Nepal sells kidney to meet basic needsGlobal TimesThe broker had taken him to Madras, India's kidney capital where the organs sell for more than 7,000 US dollars on the black market. Gyan Bahadur who was earlier assured of prov…
Paragonix Technologies Inc., Announces Filing of a 510(k) Pre-Marketing Notification Application with the US Food and …
Paragonix Technologies, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application ) with the US Food and Drug Administration for its Paragonix Sherpa Pak™ Cardiac Transport System1,2 .
Villagers in Eastern Nepal sells kidney to meet basic needs – Nzweek
Villagers in Eastern Nepal sells kidney to meet basic needsNzweekThe broker had taken him to Madras, India's kidney capital where the organs sell for more than 7,000 U.S. dollars on the black market. Gyan Bahadur who was earlier assured of providin…